Cleidocranial dysplasia plus vascular anomalies with 6p21.2 microdeletion spanning RUNX2 and VEGF [4]

American Journal of Medical Genetics

Volumn 140 A, Issue 4, 2006, Pages 398-401

  Izumi, Kosuke ^a   Yahagi, Naohisa ^b   Fujii, Yasushi ^b   Higuchi, Masataka ^a   Kosaki, Rika ^c   Naito, Yoko ^a   Nishimura, Gen ^d   Hosokai, Noboru ^e   Takahashi, Takao ^a   Kosaki, Kenjiro ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YOKOHAMA MUNICIPAL CITIZEN'S HOSPITAL   (Japan)

^c National Children Medical Center   (Japan)

^d TOKYO METROPOLITAN CHILDREN'S MEDICAL CENTER   (Japan)

^e LSI MEDIENCE CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR RUNX2; VASCULOTROPIN;

CASE REPORT; CHILD DEVELOPMENT; CHROMOSOME 6P; CHROMOSOME DELETION; CLEIDOCRANIAL DYSPLASIA; CLINICAL FEATURE; CONGENITAL BLOOD VESSEL MALFORMATION; DISEASE COURSE; GENE LOCUS; GENE SEQUENCE; HUMAN; LETTER; MALE; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL;

CARDIOVASCULAR ABNORMALITIES; CHROMOSOMES, HUMAN, PAIR 6; CLEIDOCRANIAL DYSPLASIA; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE DELETION; HUMANS; INFANT; MALE; MUSCULOSKELETAL ABNORMALITIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 32444440033     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.a.31061     Document Type: Letter

References (11)

1. Awata T, Inoue K, Kurihara S, Ohkuho T, Watanabe M, Inukai K, Inone I, Katayama S. 2002. A common polymorphism in the 5′-untranslated region of the Vegf gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51:1635-1639.
2. Cai WW, Mao JH, Chow CW, Damani S, Balmain A, Bradley A. 2002. Genome-wide detection of chromosomal imbalances in tumors using BAC microarrays. Nat Biotechnol 20:393-396.
3. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. 1997. Osf2/cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89:747-754.
4. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. 2002. The human genome browser at ucsc. Genome Res 12:996-1006.
5. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. 1997. Targeted disruption of cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
6. Lambrechts D, Carmeliet P. 2004. Genetics in zebrafish, mice, and humans to dissect congenital heart disease: Insights in the role of vegf. Curr Top Dev Biol 62:189-224.
7. Lee B, Thirunavukkarasu K, Zhou L, Pastore L, Baldini A, Hecht J, Geoffroy V, Ducy P, Karsenty G. 1997. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor osf2/cbfa1 in cleidocranial dysplasia. Nat Genet 16:307-310.
8. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll JH, Owen MJ, Mertelsmann R, Zabel BU, Olsen BR. 1997. Mutations involving the transcription factor cbfa1 cause cleidocranial dysplasia. Cell 89:773-779.
9. Patni VM, Godewar DR, Pillai KG, Tupkari JV. 1984. Cleidocranial dysostosis associated with cardiovascular disease-A case report. J Indian Dent Assoc 56:141-144.
10. Schmickel RD. 1986. Contiguous gene syndromes: A component of recognizable syndromes. J Pediatr 109:231-241.
11. Stalmans I, Lambrechts D, De Smet F, Jansen S, Wang J, Maity S, Kneer P, von der Ohe M, Swillen A, Maes C, Gewillig M, Molin DG, Hellings P, Boetel T, Haardt M, Compernolle V, Dewerchin M, Plaisance S, Vlietinck R, Emanuel B, Gittenberger-de Groot AC, Scambler P, Morrow B, Driscol DA, Moons L, Esguerra CV, Carmeliet G, Behn-Krappa A, Devriendt K, Collen D, Conway SJ, Carmeliet P. 2003. Vegf: A modifier of the del22q11 (DiGeorge) syndrome? Nat Med 9:173-182.